TENAGRITY SOLUTIONS, LLC lobbying for SOTER BIO INC.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Texas

Official filing document

Lobbyists on this filing 1

JENNY CAROLINE DEBERRY

Previously held: Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 4

Defense, Dept of (DOD)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Health Issues

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

Defense

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

Disaster Planning/Emergencies

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity. Arranging DoW CBRN visit to facility.

Budget/Appropriations

Establishing Congressional and Depts of War and Health & Human Services awareness of Soter Bios impending capabilities; submitting FY27 HHS appropriations requests to ensure proper funding for domestic pharmaceutical manufacturing capacity, critical for disaster preparedness